Minirab 20 Tablet is a delayed-release tablet containing 20mg of Rabeprazole, a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and duodenal ulcers. It is also indicated for the treatment of heartburn and other symptoms associated with gastroesophageal reflux. Minirab 20 Tablet works by inhibiting the enzyme system responsible for secreting stomach acid, thereby reducing the production of gastric acid and relieving symptoms. The tablet is designed to release the active ingredient slowly over a period of time, allowing for consistent and prolonged suppression of gastric acid secretion. In clinical trials, Minirab 20 Tablet was shown to be effective in reducing symptoms of GERD, erosive esophagitis, and duodenal ulcers, and was well-tolerated with few side effects. It is recommended for adults and children 12 years and older, and should be taken as directed by a healthcare professional.